Literature DB >> 28448751

Role of PU.1 Expression as an Inflammatory Marker in Experimental Autoimmune Uveoretinitis.

Akihiko Umazume1,2, Takeshi Kezuka1, Ryusaku Matsuda1, Yoshihiko Usui1, Hiroki Takahashi1, Naoyuki Yamakawa1, Takuya Yashiro2, Chiharu Nishiyama2, Hiroshi Goto1.   

Abstract

PURPOSE: PU.1 is an Ets family transcription factor, which is essential for the development of immune system through generation of myeloid and lymphoid lineages. In this study, we investigated PU.1 expression in the retina of mice with experimental autoimmune uveoretinitis (EAU) and the association between PU.1 expression level and inflammation in EAU.
METHODS: IRBP 1-20 peptide-immunized mice were used. Quantitative PCR, ELISA analysis, cytometric bead array (CBA), assay and immunostaining were conducted using ocular tissues and lymph nodes.
RESULTS: Quantitative PCR showed significant increases in mRNA levels of PU.1 in the retina at the peak of inflammation. Immunostaining of retina flat mounts revealed that most PU.1-positive cells were co-stained with anti-CD11c and anti-F4/80 antibodies. PU.1 knockdown in lymph node cells significantly suppressed IRBP-stimulated IFN-γ production measured by ELISA and IL-2 production measured by CBA.
CONCLUSION: PU.1 may play crucial roles in the development and progression of inflammation in EAU.

Entities:  

Keywords:  Antigen-specific inflammation; IFN-γ; IL-17; PU.1; experimental autoimmune uveitis

Mesh:

Substances:

Year:  2017        PMID: 28448751     DOI: 10.1080/09273948.2017.1299867

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

1.  Expression profile of PU.1 in CD4+T cells from patients with systemic lupus erythematosus.

Authors:  Nan Xiang; Xuan Fang; Xiao-Ge Sun; Ying-Bo Zhou; Yan Ma; Chen Zhu; Xiang-Pei Li; Guo-Sheng Wang; Jin-Hui Tao; Xiao-Mei Li
Journal:  Clin Exp Med       Date:  2021-05-08       Impact factor: 3.984

Review 2.  The role of a key transcription factor PU.1 in autoimmune diseases.

Authors:  Yilong Fang; Weile Chen; Zhe Li; Yu Chen; Xuming Wu; Xiangling Zhu; Huihui Wang; Xiaochun Chen; Qiuni Liang; Jinghua Huang; Xintong Han; Wenming Hong; Xinming Wang; Wei Wei; Zhiying Yu; Jiajie Tu
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

3.  ROS production and mitochondrial dysfunction driven by PU.1-regulated NOX4-p22phox activation in Aβ-induced retinal pigment epithelial cell injury.

Authors:  Junran Sun; Jieqiong Chen; Tong Li; Peirong Huang; Jie Li; Mengxi Shen; Min Gao; Yang Sun; Jian Liang; Xiaomeng Li; Yimin Wang; Yushu Xiao; Xiang Shi; Yifan Hu; Jingyang Feng; Huixun Jia; Te Liu; Xiaodong Sun
Journal:  Theranostics       Date:  2020-09-19       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.